Clinical trials
Terminated Phase 2 Thrombocythemia, Essential trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 2 |
| Baylor College of Medicine | 1 |
| Fred Hutchinson Cancer Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Incyte Corporation | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| OHSU Knight Cancer Institute | 1 |
| Sierra Oncology LLC - a GSK company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 10 |
| Myeloproliferative Disorders | 9 |
| Polycythemia Vera | 9 |
| Primary Myelofibrosis | 8 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Myelodysplastic Syndromes | 3 |
| Anemia, Refractory | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Blast Crisis | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.